Literature DB >> 6164925

Production of immune interferon by murine T-cell clones from long-term cultures.

F Marcucci, M Waller, H Kirchner, P Krammer.   

Abstract

Production of leukocyte interferon (IFN-alpha) and fibroblast interferon (IFN-beta) can be induced by a variety of agents but immune interferon, IFN-gamma, is only obtained when lymphoid cells are stimulated by specific antigens, allo-antigens or T-cell mitogens. Moreover, in bulk cultures, only small quantities of IFN-gamma are produced. The type of cell producing IFN-gamma has not been unambiguously defined and so we set out to determine whether a pure T-cell population could produce it, exploiting the knowledge that T cells can be maintained indefinitely in tissue culture by the addition of T-cell growth factors. Although not all T cells can found long-term cultures of this kind, cultures of antigen-specific helper, suppressor and killer T cells have been obtained in this way. We now describe the production of substantial amounts of INF-gamma when some (but not all) murine T-cell clones derived from such cultures are stimulated by either concanavalin A (Con A) or phytohaemagglutinin (PHA).

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6164925     DOI: 10.1038/291079a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  25 in total

1.  Effect of anticancer drugs on the release of interferon gamma in vitro.

Authors:  K Ahmed; P H van der Meide; J L Turk
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

Review 2.  Interferons, a group of multiple lymphokines.

Authors:  H Kirchner
Journal:  Springer Semin Immunopathol       Date:  1984

3.  Interferons as antitumor agents.

Authors:  H Kirchner
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

4.  The activity of lymphokines secreted by normal and malignant T cells.

Authors:  P H Krammer; U Hamann; L Hültner; B Kaltmann; U Kees; C Kubelka; D Gemsa
Journal:  Springer Semin Immunopathol       Date:  1984

5.  Increased expression of Ia antigens on resting B cells: an additional role for B-cell growth factor.

Authors:  R Noelle; P H Krammer; J Ohara; J W Uhr; E S Vitetta
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

6.  [Effectiveness of gamma interferon and alpha interferon in hairy cell leukemia].

Authors:  N Niederle; C Doberauer; O Kloke; K Höffken; C G Schmidt
Journal:  Klin Wochenschr       Date:  1987-07-15

7.  Studies on macrophage-activating factor (MAF) in antitumor immune responses. II. Molecular characterization of MAF produced by the tumor-immune Lyt-1+2- T cell subset.

Authors:  H Nakajima; Y Izumi; S Sugihara; Y Satoh; S Isumi; T Gotoh; H Fujiwara; T Hamaoka
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

8.  Monoclonal antibodies against murine gamma interferon.

Authors:  M Prat; G Gribaudo; P M Comoglio; G Cavallo; S Landolfo
Journal:  Proc Natl Acad Sci U S A       Date:  1984-07       Impact factor: 11.205

9.  The mEPN scheme: an intuitive and flexible graphical system for rendering biological pathways.

Authors:  Tom C Freeman; Sobia Raza; Athanasios Theocharidis; Peter Ghazal
Journal:  BMC Syst Biol       Date:  2010-05-17

10.  Specific adoptive immunotherapy of malignant glioma with long-term cytotoxic T lymphocyte line expanded in T-cell growth factor. Experimental study and future prospects.

Authors:  T Yamasaki; H Handa; J Yamashita; Y Watanabe; Y Namba; M Hanaoka
Journal:  Neurosurg Rev       Date:  1984       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.